Condition: Aortic Valve Stenosis · Chronic Kidney Diseases · Renal Failure Acute Chronic · Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Both contrast-induced acute kidney injury (AKI) and pre-existing chronic kidney disease are associated with an increased mortality risk in patients requiring aortic valve replacement. Nonetheless, the direct haemodynamic impact of the aortic barrage (i.e. pre-renal mechanism) on renal function compromising and its reversibility in patients undergoing trans-catheter aortic valve implantation (TAVI) is unknown. This registry aims to evaluate the effect of severe aortic stenosis removal on the risk of contrast-induced acute renal injury (CI-AKI) during TAVI procedures and on renal function evolution
This description comes directly from the study's public registry record.
Enrico Romagnoli, MD, PhD · +390630154187 · enromagnoli@gmail.com
Benedetta Brancadoro · +390630154187 · benedetta.brancadoro@unicatt.it
Always discuss trial participation with your own doctor first.
| Enrico Romagnoli | Roma, RM, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07626710